Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 May 10;4(7):1061–1072. doi: 10.1158/1940-6207.CAPR-11-0006

Table 4.

Predictive accuracy of HOXA9 and NID2 on head and neck cancer saliva samples. (n=51)

Predictor Sensitivity
%
Specificity
%
AUC Methylation Cutoff
value
Oral and oropharyngeal cancer (n=51)
HOXA9 63 53 0.65 13.11
NID2 72 21 0.57 11.48
Oral cancer (n=35)
HOXA9 75 53 0.75 13.11
NID2 87 21 0.73 11.48
HOXA9 and 50 90 0.75 *
NID2
*

Classified positive (+) if predicted probability for positive outcome (tumor) >= than 0.5